Abstract
Arkema has led a series B financing round for the 3-D printing polymer maker Adaptive3D. Arkema supplies some of the raw materials for Adaptive3D’s one-part, light-cured resins, which are sold into markets including health care, oil and gas, and transportation. West Pharmaceutical Services and Clear Fir Partners also participated in the series B round, as did the venture capital arm of the chip manufacturing equipment firm Applied Materials. Applied co-led Adaptive3D’s series A with DSM.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
